Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting

touchPODCAST

touchEXPERT OPINIONS for touchONCOLOGY
Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this treatment modality.
The experts

• Dr Laura Mertens, Netherlands Cancer Institute, Amsterdam, The Netherlands
• Prof. Thomas Powles, Barts Cancer Centre, London, UK
• Ms Lindsay Diamond, Icahn School of Medicine at Mount Sinai, New York, NY, USA

This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:

www.touchONCOLOGY.com